ADRB2 and prostate carcinoma: To what extent these mechanisms are involved in development of human prostate cancer is unknown, but reduced apoptotic activity and stimulation of angiogenesis may be consequences of up-regulated ADRB2 levels, which are seen in malignant compared to benign prostatic epithelial cells (Figure 3).